These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 12573535)
1. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Yoo MS; Chun HS; Son JJ; DeGiorgio LA; Kim DJ; Peng C; Son JH Brain Res Mol Brain Res; 2003 Jan; 110(1):76-84. PubMed ID: 12573535 [TBL] [Abstract][Full Text] [Related]
2. Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons. Yoo MS; Kawamata H; Kim DJ; Chun HS; Son JH Neurochem Res; 2004 Jun; 29(6):1223-34. PubMed ID: 15176479 [TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease. Anantharam V; Lehrmann E; Kanthasamy A; Yang Y; Banerjee P; Becker KG; Freed WJ; Kanthasamy AG Neurochem Int; 2007 May; 50(6):834-47. PubMed ID: 17397968 [TBL] [Abstract][Full Text] [Related]
6. Manganese induces endoplasmic reticulum (ER) stress and activates multiple caspases in nigral dopaminergic neuronal cells, SN4741. Chun HS; Lee H; Son JH Neurosci Lett; 2001 Dec; 316(1):5-8. PubMed ID: 11720765 [TBL] [Abstract][Full Text] [Related]
7. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496 [TBL] [Abstract][Full Text] [Related]
8. Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation. Zawada WM; Mrak RE; Biedermann J; Palmer QD; Gentleman SM; Aboud O; Griffin WS Acta Neuropathol Commun; 2015 Feb; 3():9. PubMed ID: 25645462 [TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity. Barzilai A; Zilkha-Falb R; Daily D; Stern N; Offen D; Ziv I; Melamed E; Shirvan A J Neural Transm Suppl; 2000; (60):59-76. PubMed ID: 11205158 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. Chun HS; Gibson GE; DeGiorgio LA; Zhang H; Kidd VJ; Son JH J Neurochem; 2001 Feb; 76(4):1010-21. PubMed ID: 11181820 [TBL] [Abstract][Full Text] [Related]
11. A Novel Non-Apoptotic Role of Procaspase-3 in the Regulation of Mitochondrial Biogenesis Activators. Kim JS; Ha JY; Yang SJ; Son JH J Cell Biochem; 2018 Jan; 119(1):347-357. PubMed ID: 28585712 [TBL] [Abstract][Full Text] [Related]
12. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
13. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease. Duda J; Pötschke C; Liss B J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375 [TBL] [Abstract][Full Text] [Related]
15. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040 [TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
20. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease. Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]